SEC v. David Banister, The Market Analysts Group, LLC — U.S. Securities and Exchange Commission Litigation Release No. 26187, dated December 10, 2024.
The SEC charged David Banister and his company, The Market Analysts Group, LLC, with fraud for misleading investors about BioVie, Inc. stock. Banister promoted the stock as a good long-term investment while secretly selling his own shares, profiting over $1.3 million through manipulative trading and false touts.
In Plain English
Imagine someone tells you a toy is super popular and a great long-term collectible, encouraging you to buy it. But secretly, they are selling all their own identical toys at the same time, making a big profit while you might overpay. That's what happened here, but with stocks. The SEC is stepping in because this person wasn't honest about their own selling plans.
Disclaimer: all facts are drawn from the SEC's own filings; the claims described are allegations unless and until a court rules or the parties settle, and some cases end in dismissal.
How the Alleged Scheme Worked
- Promoting BioVie Stock Between December 2020 and March 2021, David Banister and his company, The Market Analysts Group, LLC, promoted BioVie, Inc. stock to paying subscribers and over 60,000 followers on Stocktwits. Banister, calling himself a top market forecaster, encouraged them to 'buy and hold' BioVie shares, portraying it as a good long-term investment.
- Concealing Secret Sales While publicly touting BioVie as a long-term investment, Banister was secretly planning to sell his own substantial holdings in the same company. He failed to disclose these plans to his subscribers and followers, creating a conflict of interest.
- Creating Artificial Demand The SEC alleges Banister engaged in manipulative trading, including purchasing BioVie shares to create an 'artificial appearance of increased market demand.' These purchases were used to highlight 'recent increases in trading volume' to his audience.
- Misleading Touts Defendants touted the increased trading volume in BioVie stock, implying organic market interest. However, the complaint states these spikes were 'driven in significant part by Banister’s own purchases,' a fact he did not disclose.
- Secretly Selling Shares While encouraging others to buy and hold, Banister actively sold his own BioVie shares during the 'Relevant Period' (December 2020 to at least March 2021).
- Profiting from the Scheme As a result of this scheme, Banister pocketed approximately $1.37 million in net profits from his sales of BioVie stock.
- Harming Investors The scheme harmed other BioVie investors who were misled into buying shares at inflated prices or suffered trading losses after following Defendants' recommendations.
The Enforcement Action
The SEC filed a complaint on December 6, 2024, in the U.S. District Court for the Southern District of New York against David Banister and The Market Analysts Group, LLC. The complaint charges violations of antifraud provisions of the Securities Act of 1933, the Securities Exchange Act of 1934, and the Investment Advisers Act of 1940. The SEC seeks permanent injunctions, disgorgement with prejudgment interest, and civil penalties.
Named in this action: David Banister, The Market Analysts Group, LLC.